Literature DB >> 13933992

Antigenicity of polypeptides (poly alpha amino acids). X. Studies with polymers of D amino acids.

P H MAURER.   

Abstract

Entities:  

Keywords:  AMINO ACIDS; ANTIGENS; PEPTIDES; POLYMERS

Mesh：

Substances：

Year:  1963        PMID： 13933992     DOI： 10.3181/00379727-113-28423

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  7 in total

1.  Synthetic antigens composed exclusively of L- or D-amino acids. I. Effect of optical configuration on the immunogenicity of synthetic polypeptides in mice.

Authors:  C A Janeway; M Sela
Journal:  Immunology       Date:  1967-07       Impact factor: 7.397

2.  Relation between optical configuration and immunogenicity of synthetic polypeptides.

Authors:  F Borek; Y Stupp; S Fuchs; M Sela
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

3.  A cellular basis for genetically controlled immunologic unresponsiveness in mice: tolerance induction in T-cells.

Authors:  R K Gershon; P H Maurer; C F Merryman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

Review 4.  Echinococcus antigens.

Authors:  I G Kagan; M Agosin
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

5.  ANTIGENICITY OF POLYPEPTIDES (POLY ALPHA AMINO ACIDS). 13. IMMUNOLOGICAL STUDIES WITH SYNTHETIC POLYMERS CONTAINING ONLY D- OR D- AND L-ALPHA-AMINO ACIDS.

Authors:  P H MAURER
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

6.  ANTIGENICITY OF POLYPEPTIDES (POLY ALPHA AMINO ACIDS). XII. IMMUNOLOGICAL STUDIES WITH A NEW GROUP OF SYNTHETIC COPOLYMERS.

Authors:  P H MAURER; B F GERULAT; P PINCHUCK
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

7.  STUDIES ON ANTIGENICITY. THE RELATIONSHIP BETWEEN IN VIVO AND IN VITRO ENZYMATIC DEGRADABILITY OF HAPTEN-POLYLYSINE CONJUGATES AND THEIR ANTIGENICITIES IN GUINEA PIGS.

Authors:  B B LEVINE; B BENACERRAF
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.